The Cancer & Hematology Centers Expands in Flint with Addition of Genesee Hematology Oncology
Grand Rapids, MI – July 8, 2025 – The Cancer & Hematology Centers (CHC), Michigan’s largest physician-owned oncology and hematology practice, is proud to announce its continued expansion in Flint through the addition of Genesee Hematology Oncology. The practice, located at the Genesys Hurley Cancer Institute at 302 Kensington Avenue, brings additional depth and expertise to CHC’s growing statewide network.
Genesee Hematology Oncology has four physicians, Paul Adams, MD; Khalil Katato, MD; Alyssa Kipke, DO; and Christopher Szyarto, DO who have joined Rizwan Danish, MD and Binu Malhotra, MD to care for patients in Genesee County.
The practice treats thousands of patients annually and offers comprehensive services across the cancer care continuum, including medical oncology, and access to cutting-
Stuart Genschaw, Chief Executive Officer, The Cancer & Hematology Centers said: “Welcoming with the physicians and care team at Genesee Hematology Oncology is another important milestone for CHC in our commitment to advance independent cancer care in Michigan. Our rapid statewide growth underscores two important truths: the best physicians want to treat patients in independent settings, and patients want care close to home, delivered by doctors they trust. By aligning with the entire CHC team around the state, we are strengthening options for patients to receive cancer care in their physicians’ office, which is far more convenient and less costly than in hospitals.”
About The Cancer & Hematology Centers:
The Cancer & Hematology Centers is an independent, physician-owned oncology practice with a proud legacy of serving West Michigan and surrounding areas for over 40 years. Now with an expanded reach beyond West Michigan, we offer patients across Michigan access to cutting-edge treatments and participation in phase I, II, and III clinical trials—all within a compassionate and caring environment. Our services include benign and malignant hematology programs, outpatient specialty pharmacy services, a centralized laboratory structure and more. As a proud partner of OneOncology, a national network of leading independent community oncology practices, CHC benefits from a physician-led model that enhances our ability to improve the lives of cancer patients through shared technology platforms, data sharing, and clinical excellence.
Contact Information: [email protected]